Analyst stock forecast
BioNTech Forecast: $117.15 Analyst Target
Direct answer
BioNTech's average price target is $117.15.
The target implies +30.2% from the recorded current price, and the consensus rating is Buy.
The low target implies -15.3%, the high target implies +60.4%, and the range spans 75.7% of the current price.
Forecast evidence checked October 22, 2026.
Get free BioNTech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $89.98
- Average price target
- $117.15
- High price target
- $144.32
- Low price target
- $76.17
- Low target gap
- -15.3%
- Target upside
- +30.2%
- High target gap
- +60.4%
- Target range width
- 75.7%
- Consensus rating
- Buy
- Analysts
- 20
- Evidence date
- October 22, 2026
- Valid through
- October 29, 2026
Explore related company data
Read the frequently asked questions.
What is BioNTech's average price target?
BioNTech's verified average price target is $117.15. The target range is $76.17 to $144.32.
How far are BioNTech's low and high targets from the recorded price?
The low target implies -15.3%, while the high target implies +60.4%.
How many analysts are included in BioNTech's consensus?
The verified consensus includes 20 analysts.
How is BioNTech's target upside or downside calculated?
The average target of $117.15 is divided by the recorded price of $89.98, then one is subtracted to produce +30.2%. This does not guarantee a future return.
When was BioNTech's analyst forecast verified?
The data was verified on 2026-10-22. The dataset is valid through 2026-10-29.